Turning Point releases positive data for targeted cancer drug - STAT

Turning Point releases positive data for targeted cancer drug - STAT

STAT Plus: Turning Point releases positive data for targeted cancer drug, points to more rapid FDA filing

By MATTHEW HERPER

ED UTHMAN

Turning Point Therapeutics released positive data on repotrectinib, its targeted therapy for non-small cell lung cancer and other cancers.

READ MORE